Head And Neck Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Not yet recruiting
  • Hearing Loss
  • Head and Neck Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-14
Oct 14, 2021
U
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO
Not yet recruiting
  • Lung Cancer Metastatic
  • +7 more
  • Reduced dose intensity of IO
  • Angers, France
  • +25 more
2021-10-13
Oct 13, 2021
U
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
Active, not recruiting
  • Head and Neck Cancer
  • recombinant thyroid-stimulating hormone
  • Radiodine ablation without rhTSH
  • Brighton, England, United Kingdom
  • +24 more
2021-10-13
Oct 13, 2021
E
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Recruiting
  • Locally Advanced Solid Tumor
  • +16 more
  • Birmingham, Alabama
  • +26 more
2021-10-13
Oct 13, 2021
U
Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer
Active, not recruiting
  • Head and Neck Cancer
  • London, United Kingdom
  • +2 more
2021-10-13
Oct 13, 2021
M
Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
Active, not recruiting
  • Head And Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-10-13
Oct 13, 2021
M
Study of MEM-288 Oncolytic Virus in Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)
Not yet recruiting
  • Solid Tumor
  • +9 more
  • MEM-288 Intratumoral Injection
  • (no location specified)
2021-09-29
Sep 29, 2021
R
PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC
Active, not recruiting
  • Head and Neck Cancer
  • Amsterdam, Netherlands
  • +3 more
2021-10-12
Oct 12, 2021
U
Photoacoustic Imaging of Head and Neck Tumours
Not yet recruiting
  • Head and Neck Cancer
  • Photoacoustic Imaging Scan
  • (no location specified)
2021-09-28
Sep 28, 2021
U
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
Active, not recruiting
  • Head and Neck Cancer
  • +2 more
  • Parotid-Sparing Head & Neck Radiation Guided by MRI Sialography
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill, Department of Radia
2021-10-11
Oct 11, 2021
M
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer
Recruiting
  • Head and Neck Cancer
  • +2 more
  • Enoblituzumab
  • +2 more
  • Baltimore, Maryland
  • +40 more
2021-10-11
Oct 11, 2021
G
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +37 more
2021-10-10
Oct 10, 2021
B
Trial of BMX-001 or Placebo in Head and Neck Cancer Patients
Withdrawn
  • Head and Neck Cancer
  • (no location specified)
2021-10-04
Oct 4, 2021
C
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +6 more
2021-10-03
Oct 3, 2021
U
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Chapel Hill, North Carolina
    The University of North Carolina at Chapel Hill
2021-10-05
Oct 5, 2021
U
Quantitative Endoscopy of H&N
Active, not recruiting
  • Head and Neck Cancer
  • Spatially registered endoscopy
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-10-04
Oct 4, 2021
U
Tissue Retractors for Radiation Therapy of Head and Neck Tumors
Recruiting
  • Head and Neck Cancer
  • tissue retractors
  • Heidelberg, Germany
    University Hopsital Heidelberg
2021-09-28
Sep 28, 2021
U
Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage - 2021
Terminated
  • Head and Neck Cancer
  • Anogenital Cancer
  • Heidelberg, Germany
    UKHD, Klinik für RadioOnkologie und Strahlentherapie
2021-09-28
Sep 28, 2021
S
Normative Study to Explore Point-of-Gaze (POG), Electromyography (EMG) and Elastography Measurement of the Sternocleidomastoid (SCM) Muscle as an Outcome Variable to Track Post-Surgical Outcomes
Recruiting
  • Head and Neck Cancer
    • Singapore, Singapore
      Singapore General Hospital
    2021-09-29
    Sep 29, 2021
    A
    MAGE-A4ᶜ¹º³²T for Multi-Tumor
    Active, not recruiting
    • Urinary Bladder Cancer
    • +9 more
    • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
    • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
    • Miami, Florida
    • +10 more
    2021-10-04
    Oct 4, 2021
    I
    LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy of PVSRIPO and PVSRIPO in Combination With Anti-PD-1/L1 Checkpoint Inhibitors in Patients With Advanced Solid Tumors
    Recruiting
    • Solid Tumor
    • +2 more
    • PVSRIPO
    • Anti-PD-1 / L1
    • San Francisco, California
    • +17 more
    2021-10-04
    Oct 4, 2021
    A
    Observational Study of Dental Outcomes in Head and Neck Cancer Patients
    Active, not recruiting
    • Head and Neck Cancer
    • +3 more
      • Farmington, Connecticut
      • +5 more
      2021-09-27
      Sep 27, 2021
      A
      A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
      Recruiting
      • Pancreatic Cancer
      • +7 more
      • Glasgow, United Kingdom
      • +5 more
      2021-09-29
      Sep 29, 2021
      R
      This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
      Recruiting
      • Head and Neck Cancer
      • +7 more
      • Tumor Profiling
      • Scottsdale, Arizona
      • +2 more
      2021-09-20
      Sep 20, 2021
      I
      Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
      Active, not recruiting
      Has Results
      • Metastatic Cancer
      • +9 more
      • Mobile, Alabama
      • +19 more
      2021-08-31
      Aug 31, 2021